Imperagen raises £5 million to use quantum physics, AI on enzyme engineering
RSS SUMMARY · AGGREGATED FROM TECH CRUNCH
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
Continue Reading
The full story continues on Tech Crunch.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TECH CRUNCH
Tech
Lovable signs multi-year deal with Google Cloud to up usage 5x, source says
TECH CRUNCH·1h ago·3 min read
Tech
Defense tech is flooded with money, but who’s built to last?
TECH CRUNCH·3h ago·3 min read
Tech
Uber to put 500 data-collection vehicles on the road this year
TECH CRUNCH·4h ago·3 min read
Tech
Alphabet’s record-breaking $85B raise for Google’s AI business is a helluva good signal
TECH CRUNCH·4h ago·3 min read
Related
On this beat
Tech
Garmin says older runners are surprisingly doing the longest runs — see how you compare in the latest fascinating Connect data
TECHRADAR·30m ago·3 min read
Tech
Hey, remember that bonkers folding micro-LED TV? It’s back! And now it’s a Bugatti
TECHRADAR·30m ago·3 min read
Tech
How AI Is Driving Wearable Tech As The Future Of Personal Computing
FORBES·36m ago·3 min read
Tech
This WALL-E Self-Driving Pod Wants To Replace The Airport Wheelchair (And Much More)
FORBES·1h ago·3 min read